Summary
Both peptides fall into a similar broad context as Signal peptides, although the details of how they are used and discussed still diverge. Their typical research and application settings separate fairly clearly: BPC-157 is more often discussed in the realm of Gastroenterology, Musculoskeletal health, and Dermatology and aesthetics, whereas Epitalon is more often associated with the realm of Aging and longevity. Both appear to work through Signaling modulator, but the functional emphasis still separates, with BPC-157 leaning toward Tissue repair and healing, Angiogenesis modulation, and Anti-inflammatory and Epitalon leaning toward Mitochondrial function modulation and Antioxidant activity. Both are synthetic in origin with BPC-157 in Preclinical development and Epitalon approved for Research use only. They share some route overlap through subcutaneous injection, while the remaining routes diverge.